Summit on Access and Affordability in Cell and Gene Therapies
Join the ISSCR in Los Angeles, California in collaboration with the California Institute for Regenerative Medicine (CIRM) and UCLA Broad Stem Cell Research Center.
Save the Date: 20 March 2026
Program Description: As cell and gene therapies move from experimental treatments to approved interventions, the healthcare community faces a critical challenge: ensuring these groundbreaking therapies reach patients who need them most.
This summit brings together senior leaders in research, clinical practice, market access, policy, and patient advocacy to address the urgent need for sustainable pricing models, scalable manufacturing approaches, regulatory strategies, and innovative financing mechanisms. Through collaborative dialogue, we aim to balance continued innovation with the fundamental principle that medical breakthroughs should benefit all patients, regardless of economic circumstances or geographic location.
Summary of Sessions
Strategies for Reducing Risks and Addressing Commercial Insurer Participation
Emerging Policy for New Cell and Gene Therapy Affordability Models
Manufacturing and Regulatory Innovations
Registration will be by invitation.
This program is in collaboration with:
Program
Session Topics
Welcome and Keynote Session
Dana Goldman, PhD, University of Southern California, USA
Panel 1: Strategies for Reducing Risks and Addressing Commercial Insurer Participation
Moderator: David McLean, PhD, Emerging Therapy Solutions, USA
Phil Cyr, MPH, Precision Value & Health, USA
Harlan Levine, MD, City of Hope, USA
Panel 2: Emerging Policy for New Cell and Gene Therapy Affordability Models
Moderator: Darius Lakdawalla, PhD, University of Southern California, USA
Manar Zaghlula, PhD, Innovative Genomics Institute and University of California, Berkeley, USA
Purva Rawal, PhD, Former Chief Strategy Officer, Center for Medicare and Medicare, USA
Monica Soni , MD, Covered California, USA
Mark Walters, MD, University of California, San Francisco, USA
Panel 3: Manufacturing and Regulatory Innovations
Moderator: Amander Clark, PhD, University of California, Los Angeles, USA
Closing Keynote
Organizers
Amander Clark, PhD
University of California, Los Angeles, USA
Darius Lakdawalla, PhD
University of Southern California, USA
Deepak Srivastava, MD
Gladstone Institutes, USA
Maria Bonneville
California Institute for Regenerative Medicine (CIRM), USA
Dave McLean, PhD
Emerging Therapy Solutions, USA
Thomas A. Rando, MD, PhD
University of California, Los Angeles, USA